Whitney Sealls
-
- Diabetes Treatment and Management 5
- Diabetes, Cardiovascular Risks, and Lipoproteins 1
- Pharmacology top 10%
-
- Metabolism, Diabetes, and Cancer 6
- Peroxisome Proliferator-Activated Receptors 5
- Metabolomics and Mass Spectrometry Studies 1
-
- Pancreatic function and diabetes 2
-
- Chromium effects and bioremediation 2
-
- Adipose Tissue and Metabolism 2
- Co-authors
- Kathleen DunganJessie L. FahrbachCharles AtissoJosé Gerardo González‐GonzálezSantiago ToféThomas FörstPaul N. BlackConcetta Dirusso
- Partner nations
- United StatesMexicoGermany
In The Last Decade
Whitney Sealls
11 papers receiving 636 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Endocrinology, Diabetes and Metabolism 420
- Pharmacology 121
- Biochemistry 41
- Molecular Biology 326
- Surgery 168
Countries citing papers authored by Whitney Sealls
This map shows the geographic impact of Whitney Sealls's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Whitney Sealls with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Whitney Sealls more than expected).
Fields of papers citing papers by Whitney Sealls
This network shows the impact of papers produced by Whitney Sealls. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Whitney Sealls. The network helps show where Whitney Sealls may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Whitney Sealls, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 1 | |
| 2 | 2015 | 16 | |
| 3 | Chromium Enhances Insulin Responsiveness via AMPK | 2014 | 1 |
| 4 | 2014 | 49 | |
| 5 | Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trialbreakdown → | 2014 | 391 |
| 6 | 2014 | 0 | |
| 7 | 2011 | 45 | |
| 8 | 2011 | 17 | |
| 9 | Evidence that Hyperinsulinemia, known to Accelerate Diabetes Progression, may also Contribute to Dyslipidemia via Impairing ApoA1/ABCA1-Mediated Cholesterol Efflux | 2010 | 0 |
| 10 | 2010 | 14 | |
| 11 | 2008 | 57 | |
| 12 | 2008 | 30 | |
| 13 | 2007 | 26 |
About Whitney Sealls
Whitney Sealls is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry and Pharmacy, having authored 13 papers that have together received 647 indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (6 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Diabetes Treatment and Management (5 papers), Chromium effects and bioremediation (2 papers), Pancreatic function and diabetes (2 papers), Adipose Tissue and Metabolism (2 papers), Metabolomics and Mass Spectrometry Studies (1 paper) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (420 citations), Pharmacology (121 citations) and Biochemistry (41 citations). Whitney Sealls has collaborated with scholars based in United States, Mexico and Germany. Frequent co-authors include Kathleen Dungan, Jessie L. Fahrbach, Charles Atisso, José Gerardo González‐González, Santiago Tofé, Thomas Först, Paul N. Black, Concetta Dirusso, Jeffrey S. Elmendorf and Kirk M. Habegger.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.